We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$976M
AUM Growth
+$118M
Cap. Flow
+$533K
Cap. Flow %
0.05%
Top 10 Hldgs %
57.9%
Holding
70
New
10
Increased
18
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$29.1M
2
AXGN icon
Axogen
AXGN
+$20.1M
3
CDNA icon
CareDx
CDNA
+$18.8M
4
ARWR icon
Arrowhead Research
ARWR
+$12.5M
5
HALO icon
Halozyme
HALO
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 72.21%
2 Communication Services 3.37%
3 Energy 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
51
Pfizer
PFE
$143B
$311K 0.03%
8,926
NVS icon
52
Novartis
NVS
$297B
$307K 0.03%
3,535
BIO icon
53
Bio-Rad Laboratories Class A
BIO
$8.71B
$282K 0.03%
548
AMGN icon
54
Amgen
AMGN
$208B
$278K 0.03%
1,092
BAX icon
55
Baxter International
BAX
$13.5B
$262K 0.03%
3,258
A icon
56
Agilent Technologies
A
$39.1B
$257K 0.03%
2,548
HOLX
57
DELISTED
Hologic
HOLX
$222K 0.02%
+3,340
New +$211K
UNH icon
58
UnitedHealth
UNH
$376B
$216K 0.02%
692
ELV icon
59
Elevance Health
ELV
$81.5B
$214K 0.02%
795
GRFS
60
Grifois
GRFS
$5.36B
$176K 0.02%
10,166
ADVM
61
DELISTED
Adverum Biotechnologies
ADVM
-46,980
Closed -$9.81M
BMRN icon
62
BioMarin Pharmaceuticals
BMRN
$11.6B
-103,310
Closed -$12.7M
IONS icon
63
Ionis Pharmaceuticals
IONS
$8.6B
-129,832
Closed -$7.66M
LGND icon
64
Ligand Pharmaceuticals
LGND
$5.76B
-72,443
Closed -$5.05M
UTHR icon
65
United Therapeutics
UTHR
$25.8B
-128,138
Closed -$15.5M
GBT
66
DELISTED
Global Blood Therapeutics, Inc.
GBT
-294,316
Closed -$18.6M
HRC
67
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-2,121
Closed -$233K
GWPH
68
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-5,100
Closed -$626K
PFNX
69
DELISTED
Pfenex Inc.
PFNX
-2,348,799
Closed -$19.6M

Similar funds

First Light Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, First Light Asset Management held 70 positions worth $976M, up 14% from $858M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

First Light Asset Management's Q3 2020 filing shows 10 new, 18 increased, 14 reduced and 10 closed positions. Its largest new stake was Omnicell: 420,354 shares worth $31.4M. The largest sale was Pfenex Inc., an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 78% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q3 2020 buy was Omnicell: 420,354 shares worth $31.4M.
  • First Light Asset Management added most to CareDx in Q3 2020, an estimated $18.8M increase.
  • First Light Asset Management's biggest Q3 2020 reduction was Zymeworks, cutting an estimated $9.67M.
  • First Light Asset Management fully exited Pfenex Inc. in Q3 2020, selling an estimated $19.6M.
  • First Light Asset Management's ten largest holdings make up 58% of its $976M portfolio in Q3 2020.
  • First Light Asset Management opened 10 new positions and closed 10 in Q3 2020.
  • First Light Asset Management's portfolio value rose 14% quarter-over-quarter to $976M.

Based on First Light Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.